Biron Amin
Analyst
Piper Sandler
Equibles does not estimate personal net worth.
About Biron Amin
Biron Amin is recorded as Analyst at Piper Sandler. Biron Amin has spoken on 1 earnings call across 1 company, most recently for Kymera Therapeutics, Inc. on April 30, 2026. The companies whose calls Biron Amin spoke on are classified in the Healthcare sector.
Biron Amin on recent calls
“All right, so on Broad End 2, I noticed in the press release that you're also including adolescents in addition to adults in the trial, but I think more recently there was some inclusion criteria changes in the trial where you're now requiring, I think, adult patients.”
Affiliation history
-
Piper Sandler
Analyst
Transcript header (unverified)
Current